Previous 10 | Next 10 |
Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%,...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Greenwich LifeSciences (NASDAQ: GLSI ) is on the front lines of the ongoing battle against breast cancer. After learning about this Texas-based biotech business, you might decide to take a long-term position...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that CEO Sneh...
Presenting final 5 year immune response data from the Phase IIb clinical trial for recurring breast cancer Planning completion of GP2 manufacturing in 2nd/3rd quarter of 2021 Presenting updated design for Phase III clinical trial that is planned to commence in 3rd/4th quarter ...
Interview will air on Thursday, March 11, 2021 at 12:30 pm EST Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patien...
Gainers: Exela Technologies (XELA) +163%.Oragenics (OGEN) +47%.ReneSola (SOL) +42%.Auris Medical (EARS) +39%.The9 (NCTY) +37%.Canaan (CAN) +36%.AnPac Bio-Medical Science (ANPC) +36%.Riot Blockchain (RIOT) +35%.Washington Prime (WPG) +30%.Socket Mobile (SCKT) +23%.Losers: G...
AnPac Bio-Medical Science (ANPC) +75% after update on cancer detection system CDAPS.Second Sight Medical Products (EYES) +67%.GT Biopharma (GTBP) +45%.Auris Medical Holding Ltd. (EARS) +24%.Taoping Inc. (TAOP) +10% on launching Blockchain Business Division.AirNet Technology (ANTE) +...
Shares of Greenwich LifeSciences (NASDAQ: GLSI) were skyrocketing 48.8% higher as of 3:19 p.m. EST on Monday. The huge jump came after the company announced the hiring of Jaye Thompson as vice president of clinical and regulatory affairs. It's unusual for the addition of a new v...
Trading in microcap Greenwich LifeSciences, Inc. (GLSI) was briefly halted this afternoon following a major upswing in its share price that started around 12:45p ET and peaked at around 1:30p.Trading resumed just after 2p.At its peak at 1:27p today, Greenwich shares reached $52.27, 127% highe...
Gainers: Second Sight Medical Products (EYES) +94%.OpGen (OPGN) +71%.Anchiano Therapeutics (ANCN) +66%.GameStop (GME) +44%.Jaguar Health (JAGX) +35%.Moxian (MOXC) +30%.Koss (KOSS) +30%.Idera Pharmaceuticals (IDRA) +28%.BSQUARE (BSQR) +25%.Greenwich LifeSciences (GLSI) +23%.Losers:...
News, Short Squeeze, Breakout and More Instantly...
Greenwich LifeSciences Inc. Company Name:
GLSI Stock Symbol:
NASDAQ Market:
Greenwich LifeSciences Inc. Website:
2024-07-11 21:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAFFORD, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, tod...
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer r...